AGP Executive Report
Last update: 6 hours agoDigital Identity: Austria’s youniqx Identity opened a public sandbox for testing the European Digital Identity Wallet. Its MIA app lets users try credential-based services with fictional data; an Android version is planned. Biotech: The EU approved Rasonque for adults with metastatic pancreatic cancer after prior treatment. The authorisation covers Liechtenstein and other EEA countries, though patient access depends on national pricing and reimbursement. The EU also approved Sepalna as maintenance treatment for advanced ovarian cancer; its commercial rights include Liechtenstein. Local Tech: Swiss firm menzi ebz will distribute Follow-Me’s performer-tracking systems in Liechtenstein and Switzerland, offering planning, installation, training and support. Biometrics: Austria’s MACO Group took a majority stake in fingerprint-access maker ekey, which has a location in Liechtenstein. AI Investment: Munich startup RHISE AI raised €2.66 million to build its European personal AI, with LGT CEO Prince Max von und zu Liechtenstein among the investors.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.